Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions

Derek M. Griffith, PhD; Garima Sharma, MD; Christopher S. Holliday, PhD, MPH; Okechuku K. Enyia, MPH; Matthew Valliere, MPA; Andrea R. Semlow, MS, MPH; Elizabeth C. Stewart, DrPH, MSPH; Roger Scott Blumenthal, MD


Prev Chronic Dis. 2020;17(7):e63 

In This Article

Public Health Implications

A biopsychosocial approach takes into account not only the range of factors that determine risk but also the range of places where we might intervene within a population health framework that considers both biomedical and public health points of intervention to reduce mortality from COVID-19. We must ensure that COVID-19 screening, testing, and quarantine of all confirmed and potential cases; contact tracing; financing; and development of vaccines and clinical trials for novel therapeutic targets do not vary by sex or other socially meaningful markers of difference in our society. Moreover, we need to dramatically increase our investment in the prevention and control of chronic diseases such as hypertension, diabetes, cardiovascular diseases, chronic renal disorders, and mental health disorders that may help us to reduce COVID-19 mortality among men. We can seize this moment to reimagine and redesign our health care and public health systems to consider men's health, which would have significant benefits for our health care institutions, public health system, and economy.